《中医儿科病证诊断疗效标准·哮喘（修订）》（2018年）临床应用评价*

目的对标准进行临床应用评价，分析评价结果，对新修标准临床适用性进行客观评价。方法 分层调查本科室医生，填写小儿《中医病证诊断疗效标准适用性调查问卷》10份、《中医病证诊断疗效标准应用评价病例调查表》50份，并应用本标准评价70例哮喘患儿发作期的临床疗效。结果 适用性调查问卷评分基本集中在5分和6分，且以6分居多，对标准的赞成率100%。应用性评价中，疾病、证候诊断及分证诊断要点符合度评分以6分居多，疗效评价指标符合度评分集中在5、6分，对标准总体评分以6分居多。70例哮喘（发作期）患儿临床疗效评价，西医组有效率95%，中医组98%，2组比较，P＜0.05，差异比较具有统计学意义。结论 《中医儿科病证诊断疗效标准·哮喘（修订）》具有较好的临床指导作用，适用于临床工作。

Clinical Application Evaluation of Standard for TCM Pediatrics Clinical Diagnosis and Efficacy Asthma(Amendment) (2018)

Objective To evaluate the clinical application of the standard, analyze the evaluation results, and objectively evaluate the clinical applicability of the new standard. Methods A stratified investigation of doctors in the department, filling out 10 questionnaires on the applicability of the diagnostic criteria for the diagnosis of TCM syndromes in children, and 50 questionnaires on the application of evaluation criteria for the diagnosis and treatment of TCM syndromes,and applying the standard to evaluate the clinical efficacy of 70 asthmatic children at the onset stage. Results The applicability questionnaire scores were mainly concentrated at 5 points and 6 points, with 6 points being the majority, and the standard approval rate was 100%. In the appraisal evaluation, the disease, syndrome diagnosis and syndrome diagnosis scores were mostly scored by 6 points, the efficacy evaluation index conformity scores were concentrated at 5 and 6 points, and the standard overall score was 6 points. The clinical efficacy of 70 children with asthma(onset) was 95% in the Western medicine group and 98% in the Chinese medicine group. The difference between the two groups was P<0.05. The difference was statistically significant. Conclusion The standard for TCM pediatrics clinical diagnosis and efficacy·asthma(amendment) has a good clinical guiding role and is suitable for clinical work.